Do analysts rate ZJYL or NYXH?

Nyxoah has a consensus target price of $5.96, indicating a potential upside of 282.21%. Given Nyxoah's stronger consensus rating and higher probable upside, analysts clearly believe Nyxoah is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Nyxoah 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has stronger valuation & earnings, ZJYL or NYXH?

Jin Medical International has higher revenue and earnings than Nyxoah. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 0.75 $1.19M N/A N/A Nyxoah $11.33M 5.34 -$101.92M -$2.48 N/A

Do analysts recommend DXR or ZJYL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Daxor 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, DXR or ZJYL?

Jin Medical International has higher revenue and earnings than Daxor. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Daxor N/A N/A N/A N/A N/A Jin Medical International $20.69M 0.75 $1.19M N/A N/A

Is DXR or ZJYL more profitable?

Company Net Margins Return on Equity Return on Assets Daxor N/A N/A N/A Jin Medical International N/A N/A N/A

Does the media favor DXR or ZJYL?

In the previous week, Daxor and Daxor both had 1 articles in the media. Daxor's average media sentiment score of 1.89 beat Jin Medical International's score of 0.00 indicating that Daxor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Daxor 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Jin Medical International 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate COCH or ZJYL?

Envoy Medical currently has a consensus price target of $2.50, indicating a potential upside of 272.58%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts clearly believe Envoy Medical is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envoy Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, COCH or ZJYL?

Jin Medical International has higher revenue and earnings than Envoy Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envoy Medical $240K 214.94 -$23.76M -$1.01 N/A Jin Medical International $20.69M 0.75 $1.19M N/A N/A

Is COCH or ZJYL more profitable?

Jin Medical International has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%. Company Net Margins Return on Equity Return on Assets Envoy Medical -9,875.64% N/A -177.92% Jin Medical International N/A N/A N/A

Does the media favor COCH or ZJYL?

In the previous week, Envoy Medical had 15 more articles in the media than Jin Medical International. MarketBeat recorded 16 mentions for Envoy Medical and 1 mentions for Jin Medical International. Envoy Medical's average media sentiment score of 0.50 beat Jin Medical International's score of 0.00 indicating that Envoy Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envoy Medical 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Jin Medical International 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer ZJYL or MDAI?

Spectral AI has a consensus target price of $4.00, suggesting a potential upside of 142.42%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts plainly believe Spectral AI is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Spectral AI 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings and valuation, ZJYL or MDAI?

Jin Medical International has higher revenue and earnings than Spectral AI. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 0.75 $1.19M N/A N/A Spectral AI $19.65M 2.67 -$7.57M -$0.53 N/A

Is ZJYL or MDAI more profitable?

Jin Medical International has a net margin of 0.00% compared to Spectral AI's net margin of -85.58%. Company Net Margins Return on Equity Return on Assets Jin Medical International N/A N/A N/A Spectral AI -85.58% N/A -72.97%

Does the media refer more to ZJYL or MDAI?

In the previous week, Jin Medical International and Jin Medical International both had 1 articles in the media. Jin Medical International's average media sentiment score of 0.00 equaled Spectral AI'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jin Medical International 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Spectral AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend ZJYL or POCI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, ZJYL or POCI?

Jin Medical International has higher revenue and earnings than Precision Optics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 0.75 $1.19M N/A N/A Precision Optics $19.09M 2.46 -$5.78M -$0.63 N/A

Does the media refer more to ZJYL or POCI?

In the previous week, Jin Medical International and Jin Medical International both had 1 articles in the media. Jin Medical International's average media sentiment score of 0.00 equaled Precision Optics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jin Medical International 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Precision Optics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Jin Medical International (ZJYL) Competitors

$1.98 +0.09 (+4.47%)

Closing price 07/20/2026 03:58 PM Eastern

Extended Trading

$1.87 -0.12 (-5.79%)

As of 07/20/2026 07:34 PM Eastern

Compare

ZJYL vs. NYXH, DXR, COCH, MDAI, and POCI

Should you buy Jin Medical International stock or one of its competitors? MarketBeat compares Jin Medical International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Jin Medical International include Nyxoah (NYXH), Daxor (DXR), Envoy Medical (COCH), Spectral AI (MDAI), and Precision Optics (POCI). These companies are all part of the "medical equipment" industry.

How does Jin Medical International compare to Nyxoah?

Jin Medical International (NASDAQ:ZJYL) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk.

Nyxoah has a consensus target price of $5.96, indicating a potential upside of 282.21%. Given Nyxoah's stronger consensus rating and higher probable upside, analysts clearly believe Nyxoah is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Jin Medical International has higher revenue and earnings than Nyxoah.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	0.75	$1.19M	N/A	N/A
Nyxoah	$11.33M	5.34	-$101.92M	-$2.48	N/A

Jin Medical International has a net margin of 0.00% compared to Nyxoah's net margin of -543.21%. Jin Medical International's return on equity of 0.00% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Nyxoah	-543.21%	-163.73%	-80.24%

In the previous week, Jin Medical International had 1 more articles in the media than Nyxoah. MarketBeat recorded 1 mentions for Jin Medical International and 0 mentions for Nyxoah. Nyxoah's average media sentiment score of 1.86 beat Jin Medical International's score of 0.00 indicating that Nyxoah is being referred to more favorably in the news media.

Company	Overall Sentiment
Jin Medical International	Neutral
Nyxoah	Very Positive

Jin Medical International has a beta of 7.34, meaning that its share price is 634% more volatile than the broader market. Comparatively, Nyxoah has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market.

Summary

Jin Medical International beats Nyxoah on 7 of the 12 factors compared between the two stocks.

How does Jin Medical International compare to Daxor?

Daxor (NASDAQ:DXR) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

In the previous week, Daxor and Daxor both had 1 articles in the media. Daxor's average media sentiment score of 1.89 beat Jin Medical International's score of 0.00 indicating that Daxor is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Daxor	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Jin Medical International	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Daxor has a beta of 0.26, meaning that its share price is 74% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.34, meaning that its share price is 634% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Daxor	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Jin Medical International has higher revenue and earnings than Daxor.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Daxor	N/A	N/A	N/A	N/A	N/A
Jin Medical International	$20.69M	0.75	$1.19M	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Daxor	N/A	N/A	N/A
Jin Medical International	N/A	N/A	N/A

1.3% of Daxor shares are held by institutional investors. 51.5% of Daxor shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Daxor beats Jin Medical International on 5 of the 7 factors compared between the two stocks.

How does Jin Medical International compare to Envoy Medical?

Envoy Medical (NASDAQ:COCH) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Jin Medical International has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,875.64%	N/A	-177.92%
Jin Medical International	N/A	N/A	N/A

Jin Medical International has higher revenue and earnings than Envoy Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$240K	214.94	-$23.76M	-$1.01	N/A
Jin Medical International	$20.69M	0.75	$1.19M	N/A	N/A

Envoy Medical has a beta of 1.88, indicating that its stock price is 88% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.34, indicating that its stock price is 634% more volatile than the broader market.

In the previous week, Envoy Medical had 15 more articles in the media than Jin Medical International. MarketBeat recorded 16 mentions for Envoy Medical and 1 mentions for Jin Medical International. Envoy Medical's average media sentiment score of 0.50 beat Jin Medical International's score of 0.00 indicating that Envoy Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envoy Medical	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Jin Medical International	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

8.6% of Envoy Medical shares are held by institutional investors. 7.1% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Envoy Medical currently has a consensus price target of $2.50, indicating a potential upside of 272.58%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts clearly believe Envoy Medical is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Envoy Medical beats Jin Medical International on 8 of the 13 factors compared between the two stocks.

How does Jin Medical International compare to Spectral AI?

Jin Medical International (NASDAQ:ZJYL) and Spectral AI (NASDAQ:MDAI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, Jin Medical International and Jin Medical International both had 1 articles in the media. Jin Medical International's average media sentiment score of 0.00 equaled Spectral AI'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jin Medical International	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Spectral AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

67.1% of Spectral AI shares are held by institutional investors. 13.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Jin Medical International has higher revenue and earnings than Spectral AI.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	0.75	$1.19M	N/A	N/A
Spectral AI	$19.65M	2.67	-$7.57M	-$0.53	N/A

Jin Medical International has a beta of 7.34, indicating that its stock price is 634% more volatile than the broader market. Comparatively, Spectral AI has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market.

Spectral AI has a consensus target price of $4.00, suggesting a potential upside of 142.42%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts plainly believe Spectral AI is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Jin Medical International has a net margin of 0.00% compared to Spectral AI's net margin of -85.58%.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Spectral AI	-85.58%	N/A	-72.97%

Summary

Spectral AI beats Jin Medical International on 6 of the 11 factors compared between the two stocks.

How does Jin Medical International compare to Precision Optics?

Jin Medical International (NASDAQ:ZJYL) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

13.7% of Precision Optics shares are held by institutional investors. 14.4% of Precision Optics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jin Medical International	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Precision Optics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Jin Medical International has higher revenue and earnings than Precision Optics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	0.75	$1.19M	N/A	N/A
Precision Optics	$19.09M	2.46	-$5.78M	-$0.63	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Jin Medical International has a net margin of 0.00% compared to Precision Optics' net margin of -17.03%. Jin Medical International's return on equity of 0.00% beat Precision Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Precision Optics	-17.03%	-37.47%	-19.96%

Jin Medical International has a beta of 7.34, suggesting that its share price is 634% more volatile than the broader market. Comparatively, Precision Optics has a beta of 0.32, suggesting that its share price is 68% less volatile than the broader market.

Summary

Jin Medical International beats Precision Optics on 6 of the 9 factors compared between the two stocks.

Get Jin Medical International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZJYL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZJYL vs. The Competition

Export

Metric	Jin Medical International	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$14.87M	$8.90B	$6.89B	$12.28B
Dividend Yield	N/A	2.49%	2.67%	9.39%
P/E Ratio	N/A	16.04	27.06	23.94
Price / Sales	0.75	7.21	514.89	90.87
Price / Cash	10.37	18.55	26.68	47.25
Price / Book	0.53	3.26	10.66	6.14
Net Income	$1.19M	$230.22M	$3.60B	$331.74M
7 Day Performance	1.28%	-1.77%	-1.23%	-1.81%
1 Month Performance	-19.96%	-1.97%	1.11%	-1.44%
1 Year Performance	-84.55%	-0.92%	23.65%	16.33%

Jin Medical International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZJYL Jin Medical International	0.6542 of 5 stars	$1.99 +4.5%	N/A	-85.0%	$14.87M	$20.69M	N/A	245	News Coverage Gap Up
NYXH Nyxoah	3.9894 of 5 stars	$1.60 +0.9%	$5.96 +273.8%	-81.0%	$61.82M	$11.33M	N/A	110
DXR Daxor	2.108 of 5 stars	$10.56 -0.9%	N/A	+25.6%	$61.65M	N/A	N/A	37	Gap Down
COCH Envoy Medical	3.0927 of 5 stars	$0.74 -2.2%	$2.50 +236.9%	-58.3%	$56.43M	$240K	N/A	34	Gap Up
MDAI Spectral AI	1.8922 of 5 stars	$1.69 +1.0%	$4.00 +137.1%	-34.3%	$54.09M	$19.65M	N/A	83

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ZJYL) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jin Medical International (ZJYL) Competitors

ZJYL vs. NYXH, DXR, COCH, MDAI, and POCI

How does Jin Medical International compare to Nyxoah?

Summary

How does Jin Medical International compare to Daxor?

Summary

How does Jin Medical International compare to Envoy Medical?

Summary

How does Jin Medical International compare to Spectral AI?

Summary

How does Jin Medical International compare to Precision Optics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZJYL vs. The Competition

Jin Medical International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jin Medical International (ZJYL) Competitors

ZJYL vs. NYXH, DXR, COCH, MDAI, and POCI

How does Jin Medical International compare to Nyxoah?

Do analysts rate ZJYL or NYXH?

Which has stronger valuation & earnings, ZJYL or NYXH?

Is ZJYL or NYXH more profitable?

Does the media refer more to ZJYL or NYXH?

Which has more volatility and risk, ZJYL or NYXH?

Summary

How does Jin Medical International compare to Daxor?

Does the media favor DXR or ZJYL?

Which has more volatility & risk, DXR or ZJYL?

Do analysts recommend DXR or ZJYL?

Which has preferable earnings & valuation, DXR or ZJYL?

Is DXR or ZJYL more profitable?

Do insiders and institutionals believe in DXR or ZJYL?

Summary

How does Jin Medical International compare to Envoy Medical?

Is COCH or ZJYL more profitable?

Which has stronger earnings & valuation, COCH or ZJYL?

Which has more risk and volatility, COCH or ZJYL?

Does the media favor COCH or ZJYL?

Do institutionals and insiders believe in COCH or ZJYL?

Do analysts rate COCH or ZJYL?

Summary

How does Jin Medical International compare to Spectral AI?

Does the media refer more to ZJYL or MDAI?

Do insiders & institutionals hold more shares of ZJYL or MDAI?

Which has higher earnings and valuation, ZJYL or MDAI?

Which has more risk and volatility, ZJYL or MDAI?

Do analysts prefer ZJYL or MDAI?

Is ZJYL or MDAI more profitable?

Summary

How does Jin Medical International compare to Precision Optics?

Do institutionals & insiders believe in ZJYL or POCI?

Does the media refer more to ZJYL or POCI?

Which has preferable valuation and earnings, ZJYL or POCI?

Do analysts recommend ZJYL or POCI?

Is ZJYL or POCI more profitable?

Which has more risk and volatility, ZJYL or POCI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZJYL vs. The Competition

Jin Medical International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools